SCHEMBL3171345

SCHEMBL3171345

CC(=O)NCCNc1cc(NC(=O)C(=O)N2CCN(Cc3ccccc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 3/20 0.49
▸ ADORA2A P29274 3/20 0.49
▸ ADORA1 P30542 3/20 0.49
▸ ADORA3 P0DMS8 2/20 0.49
▸ PHGDH O43175 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ FAAH O00519 4/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3165737 0.95 ADORA2B (0.45) ADORA2BADORA2AADORA1ADORA3PHGDH
SCHEMBL3170151 0.91 ADORA2B (0.56) ADORA2BADORA2AADORA1ADORA3FAAH
SCHEMBL3173228 0.91 ADORA1 (0.47) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL3175769 0.90 ADORA2A (0.45) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL3156154 0.90 ADORA2B (0.63) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL3165340 0.89 ADORA2B (0.49) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL3164833 0.89 ADORA2B (0.49) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL3155892 0.89 ADORA2A (0.46) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL3161055 0.89 KMT2A (0.51) ALDH1A1FAAHMEN1LMNATSHR
SCHEMBL3162937 0.89 ADORA2A (0.46) ADORA2BADORA2AADORA1ADORA3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback